CNMD
CONMED Corporation
45.80$
-0.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 26.9% | 26.8% | 27.5% | 27.3% | 27.7% | 27.8% | 27.8% | 28.2% | 28.5% | 28.9% | 29.0% | 29.4% | |
| 1.3% | 1.1% | 1.5% | 1.3% | 1.7% | 1.1% | 1.5% | 1.5% | 1.7% | 1.8% | 1.5% | 1.6% | |
| 1.3% | 1.1% | 1.5% | 1.3% | 1.7% | 1.1% | 1.5% | 1.5% | 1.7% | 1.8% | 1.5% | 1.6% | |
| 9.9% | 10.5% | 10.5% | 10.5% | 10.0% | 10.3% | 9.6% | 10.1% | 9.7% | 10.7% | 9.9% | 10.4% | |
| 14.0% | 13.8% | 14.0% | 14.1% | 14.8% | 15.0% | 15.4% | 15.6% | 15.7% | 15.3% | 15.8% | 15.7% | |
| 5.2% | – | – | – | – | – | – | – | – | – | – | – | |
| 35.0% | 35.1% | 34.9% | 35.3% | 34.8% | 34.9% | 35.1% | 34.7% | 34.7% | 34.7% | 34.9% | 34.6% | |
| 28.3% | 28.2% | 27.8% | 27.7% | 27.0% | 26.8% | 26.5% | 25.8% | 25.5% | 25.0% | 24.8% | 24.5% | |
| 65.8% | 63.7% | 63.0% | 61.4% | 59.7% | 58.3% | 57.5% | 56.9% | 56.6% | 55.6% | 56.0% | 54.7% | |
| 16.2% | 13.5% | 12.6% | 11.7% | 12.2% | 12.1% | 12.3% | 12.7% | 13.6% | 13.5% | 12.6% | 19.8% | |
| 3.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 7.7% | |
| 3.5% | 3.8% | 4.4% | 4.4% | 4.5% | 4.4% | 4.2% | 4.3% | 4.6% | 4.0% | 4.6% | 4.4% | |
| 40.5% | 42.3% | 42.9% | 42.2% | 40.6% | 39.2% | 38.8% | 37.8% | 36.7% | 35.9% | 37.2% | 28.6% | |
| 34.2% | 36.3% | 37.0% | 38.6% | 40.3% | 41.7% | 42.5% | 43.1% | 43.4% | 44.4% | 44.0% | 45.3% | |
| 18.3% | 19.7% | 20.2% | 21.4% | 23.0% | 24.3% | 24.4% | 24.7% | 24.6% | 25.3% | 26.0% | 27.2% | |
| 1.4% | 1.4% | 1.4% | 1.4% | 1.3% | 1.3% | 1.4% | 1.3% | 1.3% | 1.3% | 1.3% | 1.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.